非手术治疗的急性胰腺炎患者胃肠减压的最佳证据总结

2022-07-01 复旦大学附属中山医院 护士进修杂志 发表于上海

本研究总结了采取非手术治疗的急性胰腺炎患者胃肠减压的最佳证据, 可为胃肠减压的规范性管理提供循证依据, 减少相关并发症的发生, 提升护理质量, 保证患者安全.

中文标题:

非手术治疗的急性胰腺炎患者胃肠减压的最佳证据总结

发布日期:

2022-07-01

简要介绍:

本研究总结了采取非手术治疗的急性胰腺炎患者胃肠减压的最佳证据, 可为胃肠减压的规范性管理提供循证依据, 减少相关并发症的发生, 提升护理质量, 保证患者安全.急性胰腺炎(acutepancreatitis,AP)是消化系统常见的危重疾病,具有起病迅速、变化复杂、并发症多等特点[1],且近10年来该病的发生率仍呈上升趋势,病死率约为5%~20%,对人的健康和生命造成了极大的威胁[2G3].持续胃肠减压是 AP非手术治疗的基本措施,该技术通过排出积聚在胃肠道内的气体和液体,避免胃酸大量进入十二指肠刺激胰腺分泌,进而减轻腹痛、腹胀和呕吐等症状[4G5],并防止腹腔内压力增高所引起的一系列严重并发症.但胃肠减压若实施不当,极有可能增添患者不适感,引起水电解质及酸碱平衡失调,增加气管误吸、肺部感染和非计划性拔管等不良事件的发生率[6],影响预后及延长住院时间.因此,确保胃肠减压实施过程中的有效性、安全性及舒适性,是护理 AP 患者的重要内容.近年来,急性胰腺炎诊治管理指南与专家共识相继提出,同时,与胃肠减压相关的临床决策及推荐意见也日益增多.但由于内容覆盖面积较广,极少针对非手术治疗急性胰腺炎患者的胃肠减压实践及管理展开系统化阐述;因此,本研究运用循证方法对该主题内容下的证据进行高度精炼及总结分析,旨在为临床护理实践提供科学、规范的理论依据及可操作性指导.

相关资料下载:
[AttachmentFileName(sort=1, fileName=非手术治疗的急性胰腺炎患者胃肠减压的最佳证据总结.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bbefa1c0028ea83e, title=非手术治疗的急性胰腺炎患者胃肠减压的最佳证据总结, enTitle=, guiderFrom=护士进修杂志, authorId=0, author=, summary=本研究总结了采取非手术治疗的急性胰腺炎患者胃肠减压的最佳证据, 可为胃肠减压的规范性管理提供循证依据, 减少相关并发症的发生, 提升护理质量, 保证患者安全. , cover=https://img.medsci.cn/Random/medical-dummies-PHQD475.jpg, journalId=0, articlesId=null, associationId=2131, associationName=复旦大学附属中山医院, associationIntro=复旦大学附属中山医院, copyright=0, guiderPublishedTime=Fri Jul 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span class="fontstyle0">本研究总结了采取非手术治疗的急性胰腺炎患者胃肠减压的最佳证据</span><span class="fontstyle1">, </span><span class="fontstyle0">可为胃肠减压的规范性管理提供循证依据</span><span class="fontstyle1">, </span><span class="fontstyle0">减少相关并发症的发生</span><span class="fontstyle1">, </span><span class="fontstyle0">提升护理质量</span><span class="fontstyle1">, </span><span class="fontstyle0">保证患者安全</span><span class="fontstyle1">.急性胰腺炎(acutepancreatitis,AP)是消化系统常见的危重疾病,具有起病迅速、变化复杂、并发症多等特点[1],且近10年来该病的发生率仍呈上升趋势,病死率约为5%~20%,对人的健康和生命造成了极大的威胁[2G3].持续胃肠减压是 AP非手术治疗的基本措施,该技术通过排出积聚在胃肠道内的气体和液体,避免胃酸大量进入十二指肠刺激胰腺分泌,进而减轻腹痛、腹胀和呕吐等症状[4G5],并防止腹腔内压力增高所引起的一系列严重并发症.但胃肠减压若实施不当,极有可能增添患者不适感,引起水电解质及酸碱平衡失调,增加气管误吸、肺部感染和非计划性拔管等不良事件的发生率[6],影响预后及延长住院时间.因此,确保胃肠减压实施过程中的有效性、安全性及舒适性,是护理 AP 患者的重要内容.近年来,急性胰腺炎诊治管理指南与专家共识相继提出,同时,与胃肠减压相关的临床决策及推荐意见也日益增多.但由于内容覆盖面积较广,极少针对非手术治疗急性胰腺炎患者的胃肠减压实践及管理展开系统化阐述;因此,本研究运用循证方法对该主题内容下的证据进行高度精炼及总结分析,旨在为临床护理实践提供科学、规范的理论依据及可操作性指导.</span></p>, tagList=[TagDto(tagId=322, tagName=急性胰腺炎)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=322, articleKeyword=急性胰腺炎, articleKeywordNum=6, guiderKeywordId=322, guiderKeyword=急性胰腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其它, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2449, appHits=96, showAppHits=0, pcHits=218, showPcHits=2353, likes=1, shares=13, comments=5, approvalStatus=1, publishedTime=Sat Dec 24 20:25:00 CST 2022, publishedTimeString=2022-07-01, pcVisible=1, appVisible=1, editorId=0, editor=QIAN LIN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=QIAN LIN, createdTime=Tue Dec 20 15:46:40 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Fri Jan 05 18:05:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=非手术治疗的急性胰腺炎患者胃肠减压的最佳证据总结.pdf)])
非手术治疗的急性胰腺炎患者胃肠减压的最佳证据总结.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2107327, encodeId=34c9210e3275a, content=转发学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:59 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107326, encodeId=47c7210e326c8, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:54 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107325, encodeId=0695210e325ba, content=学习受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:50 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107323, encodeId=fd6a210e32315, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230110/5ba0e7285a774e798ca6f3e5e1aace6d/59c7fc49a4b3408fb5fb40558bf2a1b2.jpg, createdBy=3a748438970, createdName=胡筋骨, createdTime=Sat Dec 24 21:04:05 CST 2022, time=2022-12-24, status=1, ipAttribution=四川省)]
    2022-12-24 delianjihui 来自新疆

    转发学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2107327, encodeId=34c9210e3275a, content=转发学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:59 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107326, encodeId=47c7210e326c8, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:54 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107325, encodeId=0695210e325ba, content=学习受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:50 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107323, encodeId=fd6a210e32315, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230110/5ba0e7285a774e798ca6f3e5e1aace6d/59c7fc49a4b3408fb5fb40558bf2a1b2.jpg, createdBy=3a748438970, createdName=胡筋骨, createdTime=Sat Dec 24 21:04:05 CST 2022, time=2022-12-24, status=1, ipAttribution=四川省)]
    2022-12-24 delianjihui 来自新疆

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2107327, encodeId=34c9210e3275a, content=转发学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:59 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107326, encodeId=47c7210e326c8, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:54 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107325, encodeId=0695210e325ba, content=学习受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:50 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107323, encodeId=fd6a210e32315, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230110/5ba0e7285a774e798ca6f3e5e1aace6d/59c7fc49a4b3408fb5fb40558bf2a1b2.jpg, createdBy=3a748438970, createdName=胡筋骨, createdTime=Sat Dec 24 21:04:05 CST 2022, time=2022-12-24, status=1, ipAttribution=四川省)]
    2022-12-24 delianjihui 来自新疆

    学习受益

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2107327, encodeId=34c9210e3275a, content=转发学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:59 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107326, encodeId=47c7210e326c8, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:54 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107325, encodeId=0695210e325ba, content=学习受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Sat Dec 24 22:04:50 CST 2022, time=2022-12-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2107323, encodeId=fd6a210e32315, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230110/5ba0e7285a774e798ca6f3e5e1aace6d/59c7fc49a4b3408fb5fb40558bf2a1b2.jpg, createdBy=3a748438970, createdName=胡筋骨, createdTime=Sat Dec 24 21:04:05 CST 2022, time=2022-12-24, status=1, ipAttribution=四川省)]
    2022-12-24 胡筋骨 来自四川省

    666

    0

拓展阅读

European Radiology:多模态DWI早期评估重症急性胰腺炎急性肾损伤的能力及价值

本项研究表明,肾皮质快速ADC是早期AKI的核心指标,髓质MK值可作为SAP大鼠肾损伤分级的敏感标志物。

UEGJ:急性胰腺炎与胆道恶性肿瘤的关系

急性胰腺炎患者的BTC风险升高;与对照组相比,胰腺炎后2年内诊断的BTC患者肿瘤分期更早。

Eur J Pain:双氯芬酸与曲马多缓解急性胰腺炎患者疼痛的疗效比较

双氯芬酸和曲马多均能有效控制AP疼痛,且安全性相当。

Pancreatology: 红细胞分布宽度与白蛋白比值可以预测急性胰腺炎患者的临床结局

急性胰腺炎是胰腺的急性炎症,可能由胆结石或饮酒引起,引起严重的腹痛和血液损伤。

Pancreatology:血清维生素D水平对急性胰腺炎严重程度的影响

急性胰腺炎是多种病因导致胰酶在胰腺内被激活后引起胰腺组织自身消化、水肿、出血甚至坏死的炎症反应。

Cell子刊:胆汁酸代谢组学表明鹅去氧胆酸可作为一种治疗胰腺坏死的药物

1. AP患者的胆汁酸代谢物谱与健康对照组不同。2. CDCA在急性胰腺炎的急性期降低,在恢复期升高。3. CDCA与AP患者的胰腺坏死密切相关。4. CDCA及其受体FXR可能是治疗胰腺腺泡细胞坏死

日本2015年急性胰腺炎治疗指南

日本儿科急诊学会(Japanese Society of Emergency Pediatrics) · 2016-04-21

JSHBPS指南:日本急性胰腺炎的管理(2015年)

日本肝胆胰腺外科学会(JSHBPS,Japanese Society of Hepato-Biliary-Pancreatic Surgery) · 2016-06-08

急性胰腺炎中西医结合诊疗共识意见(2017年)

中国中西医结合学会消化系统疾病专业委员会 · 2017-12-30

2018 AGA指南:急性胰腺炎的初期管理

美国胃肠病协会(AGA,American Gastroenterological Association) · 2018-02-03

中国急性胰腺炎诊治指南(2019·沈阳)

中华医学会消化病分会(胰腺疾病学组) · 2019-10-30